Angi Inc. (ANGI) awards 55,834 restricted stock units to CFO
Rhea-AI Filing Summary
Angi Inc. (ANGI) reported a grant of 55,834 restricted stock units to Andrew Russakoff, the company's Chief Financial Officer, in a transaction dated 09/17/2025. Each unit represents a contingent right to one share of Class A Common Stock and the award carries a $0 purchase price.
The award vests in three installments: approximately 7% on March 1, 2027, 43% on March 1, 2028 and 49% on March 1, 2029, subject to continued service, so the award will be fully vested on March 1, 2029.
Positive
- 55,834 restricted stock units granted to the CFO, indicating alignment of executive compensation with shareholder interests
- Time-based vesting through March 1, 2029 supports retention of senior management
Negative
- Potential dilution of 55,834 shares upon settlement, though materiality cannot be determined from this filing
- No performance-based conditions disclosed; award appears purely service-based
Insights
TL;DR: A routine executive equity grant aligning the CFO with shareholder interests; vesting schedule is service-based over ~3.5 years.
The reported Form 4 shows a standard restricted stock unit award to the CFO for 55,834 units, each converting to one share of Class A Common Stock. The staged vesting (7%/43%/49%) spreads dilution and retention incentives across 2027–2029. From a governance viewpoint, this is a customary compensation mechanism to retain senior finance leadership and link pay to continued service. The transaction does not itself disclose any performance-based conditions or cash consideration beyond the $0 price per unit.
TL;DR: The equity award appears designed for retention; size relative to total outstanding shares is not disclosed so impact is undetermined.
The Form 4 details 55,834 RSUs granted to the CFO with no exercise price and standard time-based vesting. Such awards typically serve to retain executives and align incentives with equity performance. The filing lacks information about total outstanding shares or prior holdings for context, so assessing dilution percentage or materiality to shareholders is not possible from this document alone.
FAQ
What transaction did Andrew Russakoff report on Form 4 for ANGI?
When do the restricted stock units vest for ANGI CFO's award?
What does each restricted stock unit represent in the ANGI Form 4?
Was there any cash paid for the RSUs reported in the ANGI Form 4?
Does the Form 4 show whether the RSUs are performance-based for ANGI?